Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Nov 8, 2012 · 10-Q · 39 days after period end · 0001354488-12-005637
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$376.78K | -$116.44K | -$160.44K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 8, 2012 · 39 d after period end
